Author: Khyati Shah

In a major breakthrough, India’s first mRNA-based COVID vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for Phase 2/3 clinical trails. This was informed by the Department... Read More

In a major breakthrough, India’s first mRNA-based COVID vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for Phase 2/3 clinical trails. This was informed by the Department... Read More

Talking about health-related issues continues to remain a stigma for working women in white-collar jobs across major urban cities including Hyderabad, a survey ‘Indian Women’s Health Report 2021’ taken-up by... Read More

‘The Indian Women’s Health Report 2021’ a study by Emcure Pharmaceuticals that surveyed working women of 25 to 55 years in white-collar jobs across 7 cities (Bangalore, Chennai, Delhi,... Read More

The Indian Women’s Health Report 2021 surveying 1,000 working women aged between 25 and 55 years, across seven cities, has revealed that about half the women surveyed were not comfortable... Read More

Women professionals in white-collar roles in India are not comfortable talking about their health issues due to the prevailing biases, stigmas and misperceptions, according to a recent study conducted by... Read More

BENGALURU: Indian pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday. Government authorities... Read More

BENGALURU: Indian pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday. Government authorities... Read More

New Delhi, Aug 24 (PTI) India''s first mRNA-based COVID-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for Phase 2/3 clinical trails, the Department of Biotechnology (DBT)... Read More

New Delhi, Aug 24 (PTI) India''s first mRNA-based COVID-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for Phase 2/3 clinical trails, the Department of Biotechnology (DBT)... Read More